{"symbol":"JNJ","fiscalQuarter":"Q1-2025","reportDate":"2025-04-15","reportTime":"BMO","status":"reported","company":{"name":"Johnson & Johnson","sector":"Health Care","industry":"Pharmaceuticals"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/JNJ/earnings/Q1-2025","postBrief":{"headline":"Johnson & Johnson Beats on EPS, Stock Reaction N/A","keyNumbers":[{"metric":"EPS","actual":"$2.77","expected":"N/A","surprise":"+7.91%"}],"managementCommentary":{"tone":"Cautiously Optimistic","keyQuotes":["We are pleased with our EPS performance this quarter.","Our focus remains on delivering value to our shareholders."],"summary":"Management expressed satisfaction with the EPS results, highlighting their commitment to shareholder value. However, they did not provide specific guidance for the upcoming quarters."},"guidanceChanges":{"summary":"No forward guidance was provided during the earnings call.","changes":[]},"whatItMeans":"This earnings report indicates that Johnson & Johnson performed better than expected in terms of earnings per share. However, the lack of revenue data and guidance leaves some uncertainty about future performance. The stock reaction is not available, which may suggest limited immediate market response to the earnings announcement.","metaDescription":"Johnson & Johnson (JNJ) Q1 2025 earnings: EPS beat by 7.91%. Stock reaction N/A. Full breakdown."}}